drugset / Trial / NCT01305837
Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether cyclic oral methylprednisolone once every month has an effect on the intrathecal inflammation in patients suffering from progressive multiple sclerosis.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 500 mg | Oral |